Abstract:Boursier J, Zarski JP, de Lédinghen V, et al. Determination of reliability criteria of liver stiffness evaluation by transient elastography. Hepatology 2012 Aug 16 [Epub ahead of print]. Every day, hepatologists need to determine the severity of liver disease in their patients for prognostication and treatment decision. One of the key assessments is the degree of liver fibrosis, which strongly predicts the future risk of hepatocellular carcinoma and hepatic complications (Gastroenterology 2009;136:138–148; Hepatology 2011;53:1874–1882). However, the assessment of liver fibrosis requires liver biopsy, which is invasive, costly, and unpleasant for the patient. It is also impractical to perform serial biopsies to assess disease progression in routine clinical practice (Gut 2010;59:969–974). In recent years, liver stiffness measurement by transient elastography has emerged as an attractive, noninvasive test of fibrosis (J Gastroenterol Hepatol 2010;25:1726–1731). Its accuracy in detecting advanced fibrosis and cirrhosis has been validated across different liver diseases (Gastroenterology 2008;134:960–974; Clin Gastroenterol Hepatol 2008;6:1027–1035; Hepatology 2010;51:454–462). The procedure involves simple training and is highly reproducible (Gut 2007;56:968–973). In a typical examination, an operator performs 10 liver stiffness measurements on a patient. According to the manufacturer instructions, the examination is considered reliable if ≥10 valid measurements are acquired, the success rate (number of valid acquisitions divided by the number of attempts) is <60%, and the ratio of the interquartile range to the median of 10 measurements (IQR/M) is <0.3. Although the choice of parameters sounds logical, it is surprising that the reliability criteria have not been systematically evaluated. In a recent study, Boursier et al tested the validity of the above reliability criteria in 1165 patients with chronic liver diseases (798 had chronic hepatitis C; 21% had cirrhosis). All patients underwent liver stiffness measurement within 3 months of liver biopsy. The overall accuracy in detecting F2, F3, and F4 disease was similar in patients classified as having reliable and unreliable liver stiffness measurements by the traditional criteria. The area under receiver-operating characteristics curves for liver stiffness measurement to predict various fibrosis stages was 0.81–0.92 in patients classified to have reliable measurements and 0.73–0.92 in those classified to have unreliable measurements, a nonsignificant difference. In particular, the number of successful acquisitions and the success rate had no influence on the diagnostic accuracy. The authors performed multivariate analysis and showed that fibrosis staging was independently associated with the median liver stiffness and IQR/M for all stages. Based on these 2 parameters, they proposed a new set of reliability criteria and classified the patients into 3 groups: 1Very reliable: IQR/M ≤ 0.10;2Reliable: IQR/M 0.10–0.30, or IQR/M >0.30 and median liver stiffness <7.1 kPa; and3Poorly reliable: IQR/M >0.30 and median liver stiffness ≥7.1 kPa. The rates of well-classified patients for the diagnosis of cirrhosis in the 3 groups were 90.4%, 85.8%, and 69.5%, respectively. Using the new criteria, only 9.1% of the examinations were poorly reliable. Because of its convenience and noninvasive nature, liver stiffness measurement by transient elastography has become a popular test of liver fibrosis and is even adopted as first-line screening tool for patients with chronic liver diseases in some countries. There are 2 main problems related to the use of transient elastography. First, measurement failure is common in obese subjects (Hepatology 2010;51:454–462; Hepatology 2010;51:828–835; J Gastroenterol Hepatol 2011;26:300–305). This is owing to poor transmission of shear wave and ultrasound signal through the liver parenchyma. With the development of the new XL probe, it is possible to generate low-frequency ultrasound to evaluate deeper liver tissue. As a result, the success rate of measurement can be as high as 90% even in obese patients (Hepatology 2012;55:199–208; J Hepatol 2012;56:833–839). The second problem of transient elastography is that a substantial proportion of patients are considered to have unreliable liver stiffness measurements. Based on the manufacturer's criteria including the number of successful acquisitions, success rate and IQR/M, 10–20% of the examinations are deemed unreliable (Hepatology 2010;51:828–835; J Gastroenterol Hepatol 2011;26:300-305; Gut 2012;61:409–415). This has major implications. Unreliable measurement does not only imply uncertainty in clinical decision, but also means that such patients have to undergo liver biopsy. This would increase medical costs and add risk to patients. Therefore, the validity of the reliability criteria should be scrutinized. So far, the best studied criterion is IQR/M. In a study of 256 patients with chronic hepatitis C, 28 had discordance of ≥2 stages between liver stiffness and histology (Hepatology 2009;49:1083–1089). IQR/M was the strongest predictor of discordance. Discordance occurred in 7.4% of patients with an IQR/M of <0.21 and 15.1% of those with an IQR/M of ≥0.21. Similar to the current study by Boursier et al, the number of successful acquisitions and the success rate did not influence the accuracy of measurement. That said, the authors still recommend 10 measurements per patient because few patients in their cohort had <10 successful measurements. IQR/M is a measurement of dispersion. A high IQR/M means that repeated measurements on the same patient differ much from each other, and suggests that the measurements are influenced by factors other than the fibrosis staging. These may include poor probe positioning and interference by the adjacent ribs or respiratory movements. However, it should be noted that IQR/M is a ratio. High IQR/M may occur owing to high IQR or low median liver stiffness. The study by Boursier et al clearly demonstrated that high IQR/M is less clinically relevant among patients with low liver stiffness of <7.1 kPa. In such patients, the negative predictive value of liver stiffness measurement is sufficiently high to exclude advanced fibrosis, even when the IQR/M is high. In summary, the study by Boursier et al extends our knowledge on the interpretation of liver stiffness results. Because transient elastography is noninvasive and accurate, it can be applied to most patients with chronic liver disease. Patients with liver stiffness of <7.1 kPa unlikely have advanced fibrosis regardless of IQR/M and can be safely followed in the clinic. Liver stiffness measurement may be repeated in 1–2 years to assess disease progression. For patients with liver stiffness >7.1 kPa, the reliability of measurement is determined by IQR/M. Decisions on treatment, hepatocellular carcinoma, and varices surveillance can be made for patients with high and reliable measurements. Liver biopsy can then be reserved for a small proportion of patients with liver stiffness >7.1 kPa and IQR/M >0.3.

Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection

Liver Stiffness Determined by Transient Elastography Is a Simple and Highly Accurate Predictor for Presence of Liver Cirrhosis in Clinical Routine

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

Clinical Application of Liver Stiffness Measurement in Patients with Cavernous Transformation of Portal Vein

Liver stiffness predicts progression to liver‐related events in patients with chronic liver disease – A cohort study of 14 414 patients

Alanine Aminotransferase-Based Algorithms of Liver Stiffness Measurement by Transient Elastography (fibroscan) for Liver Fibrosis in Chronic Hepatitis B.

Clinical Study on the Liver Stiffness Value Measured by FibroScan and Aspartate Transaminase-to-platelet Ratio Index for Evaluation of Hepatic Fibrosis in Patients with Chronic Hepatitis B

Liver Stiffness Measurement Can Reflect the Active Liver Necroinflammation in Population with Chronic Liver Disease: A Real-world Evidence Study

Title : Interpretation of liver stiffness measurement based approach for the monitoring of hepatitis B patients with antiviral therapy : a 2-year prospective study Running head : Liver stiffness for liver fibrosis monitoring Authors :

Liver Stiffness Measurement: Simplicity is Prerequisite for Reliability.

Assessing the Severity of Portal Hypertension: Is Liver or Spleen Stiffness Measurement an Alternative to the Gold Standard, Hepatic Vein or Porto-Systemic Pressure Gradient?

High Diagnostic Value of Transient Elastography for Advanced Fibrosis and Cirrhosis in Patients With Chronic Hepatitis Delta

Usefulness of New Shear Wave Elastography Technique for Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B: A Prospective Multicenter Study.

Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values

[Diagnostic Value of Liver Stiffness Measurement for the Evaluation of Liver Fibrosis in Nonalcoholic Fatty Liver].

Non-invasive diagnosis of portal hypertension in cirrhosis using ultrasound based elastography

Stiffness Value And Serum Biomarkers In Liver Fibrosis Staging: Study In Large Surgical Specimens In Patients With Chronic Hepatitis B

Imaging-based non-invasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline

Liver stiffness measured by two-dimensional shear-wave elastography predicts hepatic vein pressure gradient at high values in liver transplant candidates with advanced liver cirrhosis

Comparison between spleen and liver stiffness measurements by sound touch elastography for diagnosing cirrhosis at different aminotransferase levels: a prospective multicenter study

Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living with HIV and Steatotic Liver Disease